Edgewise Therapeutics, Inc. (EWTX) — Net Income
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$167.79M | -25.4% |
| 2024 | -$133.81M | -33.6% |
| 2023 | -$100.16M | -48.1% |
| 2022 | -$67.64M | -58.0% |
| 2021 | -$42.81M | -150.0% |
| 2020 | -$17.12M | — |
| Fiscal Year | Net Income | Change YoY |
|---|---|---|
| 2025 | -$167.79M | -25.4% |
| 2024 | -$133.81M | -33.6% |
| 2023 | -$100.16M | -48.1% |
| 2022 | -$67.64M | -58.0% |
| 2021 | -$42.81M | -150.0% |
| 2020 | -$17.12M | — |